Literature DB >> 17557936

Transgenic RNA interference in mice.

Xue Gao1, Pumin Zhang.   

Abstract

The discovery that small interfering RNA duplexes (siRNA) can silence gene expression in mammalian cells has revolutionized biomedical research. The most successful application of the discovery has been to study gene function in cultured human or mouse cells. However, the knockdown effect of siRNA is only transient. To achieve a more sustained gene-silencing effect, shRNA (small hairpin RNA) expressed from a vector is preferred. An additional benefit of shRNA is that RNA interference (RNAi) can now be applied in vivo through delivering shRNA-expressing vectors by transgenic technology. Transgenic RNAi not only allows the study of biological processes not present in cultured cells but also offers chronic therapeutic potentials. In this review, we will summarize the developments in the generation of transgenic RNAi mice.

Entities:  

Mesh:

Year:  2007        PMID: 17557936     DOI: 10.1152/physiol.00002.2007

Source DB:  PubMed          Journal:  Physiology (Bethesda)        ISSN: 1548-9221


  13 in total

Review 1.  Modeling human neurodegenerative diseases in transgenic systems.

Authors:  Miguel A Gama Sosa; Rita De Gasperi; Gregory A Elder
Journal:  Hum Genet       Date:  2011-12-14       Impact factor: 4.132

2.  Segment- and cell-specific expression of D-type cyclins in the postnatal mouse epididymis.

Authors:  Huizhen Wang; T Rajendra Kumar
Journal:  Gene Expr Patterns       Date:  2012-01-24       Impact factor: 1.224

3.  Production of germline transgenic prairie voles (Microtus ochrogaster) using lentiviral vectors.

Authors:  Zoe R Donaldson; Shang-Hsun Yang; Anthony W S Chan; Larry J Young
Journal:  Biol Reprod       Date:  2009-07-29       Impact factor: 4.285

4.  Down-regulation of Pkd2 by siRNAs suppresses cell-cell adhesion in the mouse melanoma cells.

Authors:  Guo-Hui Bian; Ge Cao; Xiao-Yan Lv; Qing-Wei Li; Huan Sun; Yan Xiao; Jian-Zhong Ai; Qui-Tan Yang; Jing-Jing Duan; Yi-Dong Wang; Zheng Zhang; Rui-Zhi Tan; Yu-Hang Liu; Yang Yang; Yu-Quan Wei; Qin Zhou
Journal:  Mol Biol Rep       Date:  2009-08-18       Impact factor: 2.316

Review 5.  Applications of RNA interference in cancer therapeutics as a powerful tool for suppressing gene expression.

Authors:  Song He; Dechun Zhang; Fang Cheng; Fanghong Gong; Yanan Guo
Journal:  Mol Biol Rep       Date:  2009-01-01       Impact factor: 2.316

6.  AKI after conditional and kidney-specific knockdown of stanniocalcin-1.

Authors:  Luping Huang; Tatiana Belousova; Jenny Szu-Chin Pan; Jie Du; Huiming Ju; Lianghao Lu; Pumin Zhang; Luan D Truong; Alli Nuotio-Antar; David Sheikh-Hamad
Journal:  J Am Soc Nephrol       Date:  2014-04-03       Impact factor: 10.121

7.  Nano delivers big: designing molecular missiles for cancer therapeutics.

Authors:  Sachin Patel; Ashwin A Bhirde; James F Rusling; Xiaoyuan Chen; J Silvio Gutkind; Vyomesh Patel
Journal:  Pharmaceutics       Date:  2011       Impact factor: 6.321

Review 8.  The mouse genetics toolkit: revealing function and mechanism.

Authors:  Louise van der Weyden; Jacqueline K White; David J Adams; Darren W Logan
Journal:  Genome Biol       Date:  2011-06-24       Impact factor: 13.583

9.  shRNA off-target effects in vivo: impaired endogenous siRNA expression and spermatogenic defects.

Authors:  Hye-Won Song; Anilkumar Bettegowda; Daniel Oliver; Wei Yan; Mimi H Phan; Dirk G de Rooij; Mark A Corbett; Miles F Wilkinson
Journal:  PLoS One       Date:  2015-03-19       Impact factor: 3.240

10.  Conditional gene expression systems in the transgenic rat brain.

Authors:  Kai Schönig; Tillmann Weber; Ariana Frömmig; Lena Wendler; Brigitte Pesold; Dominik Djandji; Hermann Bujard; Dusan Bartsch
Journal:  BMC Biol       Date:  2012-09-03       Impact factor: 7.431

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.